{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:40:55Z","timestamp":1792806055390,"version":"4.5.0"},"reference-count":18,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>The management of neurofibromatosis type 2 (NF2)\u2013associated meningiomas is challenging. The role of Gamma Knife radiosurgery (GKRS) in the treatment of these tumors remains to be fully defined. In this study, the authors aimed to examine the role of GKRS in the treatment of NF2-associated meningiomas and to evaluate the outcomes and complications after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>Seven international medical centers contributed data for this retrospective cohort. Tumor progression was defined as a \u2265 20% increase from the baseline value. The clinical features, treatment details, outcomes, and complications were studied. The median follow-up was 8.5 years (range 0.6\u201325.5 years) from the time of initial GKRS. Shared frailty Cox regression was used for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>A total of 204 meningiomas in 39 patients treated with GKRS were analyzed. Cox regression analysis showed that increasing the maximum dose (p = 0.02; HR 12.2, 95% CI 1.287\u2013116.7) and a lower number of meningiomas at presentation (p = 0.03; HR 0.9, 95% CI 0.821\u20130.990) were predictive of better tumor control in both univariable and multivariable settings. Age at onset, sex, margin dose, location, and presence of neurological deficit were not predictive of tumor progression. The cumulative 10-year progression-free survival was 94.8%. Radiation-induced adverse effects were noted in 4 patients (10%); these were transient and managed medically. No post-GKRS malignant transformation was noted in 287 person-years of follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>GKRS achieved effective tumor control with a low and generally acceptable rate of complications in NF2-associated meningiomas. There did not appear to be an appreciable risk of post\u2013GKRS-induced malignancy in patients with NF2-treated meningiomas.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2020.12.jns202814","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T16:24:02Z","timestamp":1628094242000},"page":"109-114","source":"Crossref","is-referenced-by-count":10,"title":["Neurofibromatosis type 2\u2013associated meningiomas: an international multicenter study of outcomes after Gamma Knife stereotactic radiosurgery"],"prefix":"10.3171","volume":"136","author":[{"given":"Nasser","family":"Mohammed","sequence":"first","affiliation":[{"name":"Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chieh","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Chytka","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Liscak","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjul","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Arsanious","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, West Virginia University, Morgantown, West Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Cifarelli","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, West Virginia University, Morgantown, West Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Perez Caceres","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Universit\u00e9 de Sherbrooke, Centre de recherche du CHUS, Sherbrooke, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mathieu","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, Universit\u00e9 de Sherbrooke, Centre de recherche du CHUS, Sherbrooke, Quebec, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herwin","family":"Speckter","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, CEDIMAT Hospital, Santo Domingo, Dominican Republic; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam U.","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, House Ear Institute, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P.","family":"Lekovic","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, House Ear Institute, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P.","family":"Sheehan","sequence":"additional","affiliation":[{"name":"Department of Neurological Surgery, University of Virginia Health System, Charlottesville, Virginia;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"6429","key":"r1","series-title":"Nature","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/363515a0","article-title":"Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2","volume":"363","author":"Rouleau GA","year":"1993","unstructured":"Rouleau GA, Merel P, Lutchman M,  Alteration in a new gene encoding a putative membrane-organizing protein causes neuro-fibromatosis type 2. Nature. 1993;363(6429):515\u2013521.10.1038\/363515a0"},{"issue":"304","key":"r2","series-title":"Q J Med","first-page":"603","article-title":"A clinical study of type 2 neurofibromatosis","volume":"84","author":"Evans DG","year":"1992","unstructured":"Evans DG, Huson SM, Donnai D,  A clinical study of type 2 neurofibromatosis. Q J Med. 1992;84(304):603\u2013618.1484939"},{"issue":"8","key":"r3","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1093\/neuonc\/nos129","article-title":"Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features","volume":"14","author":"Goutagny S","year":"2012","unstructured":"Goutagny S, Bah AB, Henin D,  Long-term follow-up of 287 meningiomas in neurofibromatosis type 2 patients: clinical, radiological, and molecular features. Neuro Oncol. 2012;14(8):1090\u20131096.2271160510.1093\/neuonc\/nos129"},{"issue":"4","key":"r4","series-title":"Am J Hum Genet","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1086\/342716","article-title":"Predictors of the risk of mortality in neurofibromatosis 2","volume":"71","author":"Baser ME","year":"2002","unstructured":"Baser ME, Friedman JM, Aeschliman D,  Predictors of the risk of mortality in neurofibromatosis 2. Am J Hum Genet. 2002;71(4):715\u2013723.10.1086\/34271612235555"},{"issue":"4","key":"r5","series-title":"Am J Med Genet","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ajmg.1320520411","article-title":"Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity","volume":"52","author":"Parry DM","year":"1994","unstructured":"Parry DM, Eldridge R, Kaiser-Kupfer MI,  Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994;52(4):450\u2013461.774775810.1002\/ajmg.1320520411"},{"issue":"3","key":"r6","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3171\/2014.10.JNS132593","article-title":"Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2","volume":"122","author":"Liu A","year":"2015","unstructured":"Liu A, Kuhn EN, Lucas JT Jr,  Gamma Knife radiosurgery for meningiomas in patients with neurofibromatosis Type 2. J Neurosurg. 2015;122(3):536\u2013542.2555519310.3171\/2014.10.JNS132593"},{"issue":"3","key":"r7","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11060-016-2257-z","article-title":"Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series","volume":"130","author":"Birckhead B","year":"2016","unstructured":"Birckhead B, Sio TT, Pollock BE,  Gamma Knife radiosurgery for neurofibromatosis type 2-associated meningiomas: a 22-year patient series. J Neurooncol. 2016;130(3):553\u2013560.10.1007\/s11060-016-2257-z27816997"},{"issue":"4","key":"r8","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/j.wneu.2015.05.068","article-title":"3D volumetric measurement of neurofibromatosis type 2-associated meningiomas: association between tumor location and growth rate","volume":"84","author":"Evers S","year":"2015","unstructured":"Evers S, Verbaan D, Sanchez E, Peerdeman S. 3D volumetric measurement of neurofibromatosis type 2-associated meningiomas: association between tumor location and growth rate. World Neurosurg. 2015;84(4):1062\u20131069.2608743410.1016\/j.wneu.2015.05.068"},{"issue":"5","key":"r9","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.3171\/2019.1.JNS183398","article-title":"Primary versus postoperative stereotactic radiosurgery for acromegaly: a multicenter matched cohort study","volume":"132","author":"Mohammed N","year":"2020","unstructured":"Mohammed N, Ding D, Hung Y-C,  Primary versus postoperative stereotactic radiosurgery for acromegaly: a multicenter matched cohort study. J Neurosurg. 2020;132(5):1507\u20131516.10.3171\/2019.1.JNS183398"},{"issue":"5","key":"r10","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"E889","DOI":"10.1093\/neuros\/nyz126","article-title":"Treatment of asymptomatic meningioma with Gamma Knife radiosurgery: long-term follow-up with volumetric assessment and clinical outcome","volume":"85","author":"Gupta A","year":"2019","unstructured":"Gupta A, Xu Z, Cohen-Inbar O,  Treatment of asymptomatic meningioma with Gamma Knife radiosurgery: long-term follow-up with volumetric assessment and clinical outcome. Neurosurgery. 2019;85(5):E889\u2013E899.3106201810.1093\/neuros\/nyz126"},{"key":"r11","series-title":"World Neurosurg","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1016\/j.wneu.2019.03.043","article-title":"Management of meningiomas involving the major venous sinuses: a single-institution experience","volume":"127","author":"Mohammed N","year":"2019","unstructured":"Mohammed N, Narayan V, Patra D,  Management of meningiomas involving the major venous sinuses: a single-institution experience. World Neurosurg. 2019;127:e179\u2013e185.3087875010.1016\/j.wneu.2019.03.043"},{"issue":"6","key":"r12","series-title":"Phys Med","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ejmp.2015.04.008","article-title":"The role of the concept of biologically effective dose (BED) in treatment planning in radiosurgery","volume":"31","author":"Millar WT","year":"2015","unstructured":"Millar WT, Hopewell JW, Paddick I,  The role of the concept of biologically effective dose (BED) in treatment planning in radiosurgery. Phys Med. 2015;31(6):627\u2013633.10.1016\/j.ejmp.2015.04.00825982304"},{"key":"r13","series-title":"Radiother Oncol","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.radonc.2018.06.039","article-title":"Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases","volume":"130","author":"Lucia F","year":"2019","unstructured":"Lucia F, Key S, Dissaux G,  Inhomogeneous tumor dose distribution provides better local control than homogeneous distribution in stereotactic radiotherapy for brain metastases. Radiother Oncol. 2019;130:132\u2013138.10.1016\/j.radonc.2018.06.03930017105"},{"key":"r14","series-title":"Medical Imaging 2019: Computer-Aided Diagnosis. Vol 10950","article-title":"Dose distribution as outcome predictor for Gamma Knife radiosurgery on vestibular schwannoma","author":"Langenhuizen P","year":"2019","unstructured":"Langenhuizen P, van Gorp H, Zinger S,  Dose distribution as outcome predictor for Gamma Knife radiosurgery on vestibular schwannoma. In: Mori K, Hahn HK, eds. Medical Imaging 2019: Computer-Aided Diagnosis. Vol 10950. SPIE; 2019."},{"issue":"4","key":"r15","series-title":"Acta Oncol","doi-asserted-by":"publisher","first-page":"453","DOI":"10.3109\/02841869309093624","article-title":"Target dose versus extratarget dose in stereotactic radiosurgery","volume":"32","author":"Lax I","year":"1993","unstructured":"Lax I. Target dose versus extratarget dose in stereotactic radiosurgery. Acta Oncol. 1993;32(4):453\u2013457.10.3109\/028418693090936248369134"},{"issue":"5","key":"r16","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/j.ijrobp.2011.10.024","article-title":"The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas","volume":"83","author":"Balagamwala EH","year":"2012","unstructured":"Balagamwala EH, Suh JH, Barnett GH,  The importance of the conformality, heterogeneity, and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas. Int J Radiat Oncol Biol Phys. 2012;83(5):1406\u20131413.2220915110.1016\/j.ijrobp.2011.10.024"},{"issue":"1","key":"r17","series-title":"Clin Genet","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1399-0004.2010.01598.x","article-title":"Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma","volume":"81","author":"Zirn B","year":"2012","unstructured":"Zirn B, Arning L, Bartels I,  Ring chromosome 22 and neurofibromatosis type II: proof of two-hit model for the loss of the NF2 gene in the development of meningioma. Clin Genet. 2012;81(1):82\u201387.10.1111\/j.1399-0004.2010.01598.x21175598"},{"issue":"1","key":"r18","series-title":"Hum Mutat","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.20393","article-title":"Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings","volume":"28","author":"Ahronowitz I","year":"2007","unstructured":"Ahronowitz I, Xin W, Kiely R,  Mutational spectrum of the NF2 gene: a meta-analysis of 12 years of research and diagnostic laboratory findings. Hum Mutat. 2007;28(1):1\u201312.10.1002\/humu.2039316983642"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/136\/1\/article-p109.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/136\/1\/article-p109.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/136\/1\/article-p109.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:50:23Z","timestamp":1792803023000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/136\/1\/article-p109.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":18,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2020.12.jns202814","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}